Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fred R Hirsch

Showing results (61-70 of 405) with videos related to

Pageof 41
Sort By:
Oncology (Williston Park, N.Y.)|December 13, 2006
Developing CT image-processing tools to accelerate progress in lung cancer drug developmentJames L Mulshine, Ricardo S Avila, Fred R Hirsch, et al.
Lung Cancer (Amsterdam, Netherlands)|April 17, 2002
The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosisRoy M Bremnes, Robert Veve, Fred R Hirsch, et al.
Lung Cancer (Amsterdam, Netherlands)|December 7, 2002
Future developments in the treatment of lung cancerFred R Hirsch, Jürgen R Fischer, Jacek Niklinski, et al.
International Journal of Oncology|May 27, 2014
Diagnostic and therapeutic issues for patients with advanced non‑small cell lung cancer harboring anaplastic lymphoma kinase rearrangement: European vs. US perspective (review)Massimo Di Maio, Filippo De Marinis, Fred R Hirsch, et al.
Lung Cancer (Amsterdam, Netherlands)|July 26, 2002
Pulmonary neuroendocrine tumors: incidence and prognosis of histological subtypes. A population-based study in DenmarkHalla Skuladottir, Fred R Hirsch, Heine H Hansen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2010
The tissue is the issue: personalized medicine for non-small cell lung cancerFred R Hirsch, Murry W Wynes, David R Gandara, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 15, 2011
Finding ALK-positive lung cancer: what are we really looking for?D Ross Camidge, Fred R Hirsch, Marileila Varella-Garcia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 27, 2022
Longitudinal Analyses of COVID-19 Vaccination in Patients With Lung Cancer: Antibody Responses and Variant-Specific NeutralizationPhilip C Mack, Fred R Hirsch, Paul A Bunn, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 3, 2026
Lung Cancer in Never Smokers: Genetics, Epidemiology, Environmental Exposures, and Distinct Immune LandscapeJiahua Lu, Elaine Shum, Robert M Samstein, et al.
Cancers|February 11, 2023
Tumor Treating Fields (TTFields) Therapy Concomitant with Taxanes for Cancer TreatmentIgnace Vergote, Teresa Macarulla, Fred R Hirsch, et al.
Pageof 41

Showing results (61-70 of 405) with videos related to

Sort By:
Pageof 41
Oncology (Williston Park, N.Y.)|December 13, 2006
Developing CT image-processing tools to accelerate progress in lung cancer drug developmentJames L Mulshine, Ricardo S Avila, Fred R Hirsch, et al.
Lung Cancer (Amsterdam, Netherlands)|April 17, 2002
The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosisRoy M Bremnes, Robert Veve, Fred R Hirsch, et al.
Lung Cancer (Amsterdam, Netherlands)|December 7, 2002
Future developments in the treatment of lung cancerFred R Hirsch, Jürgen R Fischer, Jacek Niklinski, et al.
International Journal of Oncology|May 27, 2014
Diagnostic and therapeutic issues for patients with advanced non‑small cell lung cancer harboring anaplastic lymphoma kinase rearrangement: European vs. US perspective (review)Massimo Di Maio, Filippo De Marinis, Fred R Hirsch, et al.
Lung Cancer (Amsterdam, Netherlands)|July 26, 2002
Pulmonary neuroendocrine tumors: incidence and prognosis of histological subtypes. A population-based study in DenmarkHalla Skuladottir, Fred R Hirsch, Heine H Hansen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2010
The tissue is the issue: personalized medicine for non-small cell lung cancerFred R Hirsch, Murry W Wynes, David R Gandara, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 15, 2011
Finding ALK-positive lung cancer: what are we really looking for?D Ross Camidge, Fred R Hirsch, Marileila Varella-Garcia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 27, 2022
Longitudinal Analyses of COVID-19 Vaccination in Patients With Lung Cancer: Antibody Responses and Variant-Specific NeutralizationPhilip C Mack, Fred R Hirsch, Paul A Bunn, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 3, 2026
Lung Cancer in Never Smokers: Genetics, Epidemiology, Environmental Exposures, and Distinct Immune LandscapeJiahua Lu, Elaine Shum, Robert M Samstein, et al.
Cancers|February 11, 2023
Tumor Treating Fields (TTFields) Therapy Concomitant with Taxanes for Cancer TreatmentIgnace Vergote, Teresa Macarulla, Fred R Hirsch, et al.
Pageof 41